DPP4is are known to exhibit a better glucose-lowering effect in Asians compared to other ethnic groups due to differences in the pathophysiology of T2DM by ethnic group, with predominance of insulin secretory defect resulting from greater β-cell deficiency in Asians [10–12]. This evidence concerns the gene INS and type 2 diabetes mellitus.